Construction and results of a comprehensive index for gastrointestinal health monitoring in China: a nationwide study

Zhi-Yuan Cheng, Ye Gao, Fan Mao, Han Lin, Ying-Ying Jiang, Ting-Ling Xu, Chang Sun, Lei Xin, Zhao-Shen Li, Rong Wan, Mai-Geng Zhou, Luo-Wei Wang, China Gastrointestinal Health Expert Group (CGHEG), Mai-Geng Zhou, Ya-Min Bai, Li-Min Wang, Cheng-Shi Yu, Ying-Ying Jiang, Fan Mao, Wen-Qiang Wei, Wan-Qing Chen, Yu-Hui Zhang, Jian-Ping Hu, Zhao-Shen Li, Luo-Wei Wang, Zhen-Dong Jin, Yi-Qi Du, Min-Hu Chen, Ying-Lian Xiao, Ren Mao, Xiao-Hua Hou, Jia-Ming Qian, Hong Yang, Li-Ya Zhou, Nong-Hua Lv, Duo-Wu Zou, Bang-Mao Wang, Bin Lv, Jing-Yuan Fang, Kai-Chun Wu, Yan-Qing Li, Xiao-Ping Zou, Zhi-Yuan Cheng, Ye Gao, Fan Mao, Han Lin, Ying-Ying Jiang, Ting-Ling Xu, Chang Sun, Lei Xin, Zhao-Shen Li, Rong Wan, Mai-Geng Zhou, Luo-Wei Wang, China Gastrointestinal Health Expert Group (CGHEG), Mai-Geng Zhou, Ya-Min Bai, Li-Min Wang, Cheng-Shi Yu, Ying-Ying Jiang, Fan Mao, Wen-Qiang Wei, Wan-Qing Chen, Yu-Hui Zhang, Jian-Ping Hu, Zhao-Shen Li, Luo-Wei Wang, Zhen-Dong Jin, Yi-Qi Du, Min-Hu Chen, Ying-Lian Xiao, Ren Mao, Xiao-Hua Hou, Jia-Ming Qian, Hong Yang, Li-Ya Zhou, Nong-Hua Lv, Duo-Wu Zou, Bang-Mao Wang, Bin Lv, Jing-Yuan Fang, Kai-Chun Wu, Yan-Qing Li, Xiao-Ping Zou

Abstract

Background: The disease burden of gastrointestinal disease (GD) in China is high, with significant variation across provinces. A comprehensive agreed set of indicators could guide rational resource allocation to support better GD outcomes.

Methods: This study collected data from multiple sources, including national surveillance, surveys, registration systems, and scientific research. Literature reviews and Delphi methods were used to obtain monitoring indicators; the analytic hierarchy process was used to determine indicator weights.

Findings: The China Gastrointestinal Health Index (GHI) system consisted of four dimensions and 46 indicators. The weight of the four dimensions from high to low included the prevalence of gastrointestinal non-neoplastic diseases and gastrointestinal neoplasms (GN) (0.3246), clinical treatment of GD (0.2884), prevention and control of risk factors (0.2606), and exposure to risk factors (0.1264). The highest indicator weight of GHI rank was the successful smoking cessation rate (0.1253), followed by the 5-year survival rate of GN (0.0905), and the examination rate of diagnostic oesophagogastroduodenoscopy (0.0661). The overall GHI for China in 2019 was 49.89, varying from 39.19 to 76.13 across all sub-regions. The top five sub-regions in the total GHI score were in the eastern region.

Interpretation: GHI is the first system designed to monitor gastrointestinal health systematically. In the future, data from sub-regions of China should be used to test and improve the GHI system for its impact.

Funding: This research was supported by the National Health Commission of China, the First Affiliated Hospital of Naval Medical University (2019YXK006), and the Science and Technology Commission of Shanghai Municipality (21Y31900100).

Keywords: Analytic hierarchy process; China gastrointestinal health index; Delphi method; Index system; Monitoring; Weight.

Conflict of interest statement

Luo-Wei Wang has received research support from the National Health Commission of China, the First Affiliated Hospital of Naval Medical University (2019YXK006), and the Science and Technology Commission of Shanghai Municipality (21Y31900100). All other authors declare no competing interests.

© 2023 Published by Elsevier Ltd.

Figures

Fig. 1
Fig. 1
Process of constructing of GHI.
Fig. 2
Fig. 2
Flowchart of Delphi process.
Fig. 3
Fig. 3
Procedure of AHP.
Fig. 4
Fig. 4
GHI scores of provinces in China.

References

    1. Vos T., Lim S.S., Abbafati C., et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–1222.
    1. Sung H., Ferlay J., Siegel R.L., et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
    1. Qiu H., Cao S., Xu R. Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Commun. 2021;41(10):1037.
    1. Arnold M., Abnet C.C., Neale R.E., et al. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology. 2020;159(1):335–349.e15.
    1. Xiao J., Wang F., Wong N.K., et al. Global liver disease burdens and research trends: analysis from a Chinese perspective. J Hepatol. 2019;71(1):212–221.
    1. Jairath V., Feagan B.G. Global burden of inflammatory bowel disease. Lancet Gastroenterol Hepatol. 2020;5(1):2–3.
    1. Xie X., Ren K., Zhou Z., Dang C., Zhang H. The global, regional and national burden of peptic ulcer disease from 1990 to 2019: a population-based study. BMC Gastroenterol. 2022;22(1):58.
    1. Ouyang G., Pan G., Liu Q., et al. The global, regional, and national burden of pancreatitis in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. BMC Med. 2020;18(1):388.
    1. Tung K.T.S., Wong R.S., Ho F.K., et al. Development and validation of indicators for population injury surveillance in Hong Kong: development and usability study. JMIR Public Health Surveill. 2022;8(8)
    1. Li Y., Zhang C., Zhan P., Fu H., Yip W. Trends and projections of universal health coverage indicators in China, 1993–2030: an analysis of data from four nationwide household surveys. Lancet Reg Health West Pac. 2023;31
    1. World Health Organization Global action plan for the prevention and control of noncommunicable diseases 2013-2020 [Internet] 2013. iii, 103 p. Available from:
    1. Peery A.F., Crockett S.D., Murphy C.C., et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2021. Gastroenterology. 2022;162(2):621–644.
    1. CPC Central Committee State Council the plan for “Healthy China 2030” 2016 [Internet] Available from:
    1. China’s medium and long-term plan for the prevention and treatment of chronic diseases (2017-2025) [Internet] Available from:
    1. Work plan for comprehensively improving the comprehensive capacity of county-level hospitals (2018-2020) [Internet] Available from:
    1. Bai Y., Zhang Y., Zotova O., et al. Healthy cities initiative in China: progress, challenges, and the way forward. Lancet Reg Health West Pac. 2022;27
    1. So W.K.W., Chan D.N.S., Law B.M.H., Rana T., Wong C.L. Achieving equitable access to cancer screening services to reduce the cancer burden in the Asia-Pacific region: experience from Hong Kong. Lancet Reg Health West Pac. 2022;29
    1. Xu L., Zhou C., Luo S., Chan D.K., McLaws M.L., Liang W. Modernising infectious disease surveillance and an early-warning system: the need for China’s action. Lancet Reg Health West Pac. 2022;23
    1. Schottinger J.E., Jensen C.D., Ghai N.R., et al. Association of physician adenoma detection rates with postcolonoscopy colorectal cancer. JAMA. 2022;327(21):2114.
    1. Global Burden of Disease 2019 Cancer Collaboration. Kocarnik J.M., Compton K., et al. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. JAMA Oncol. 2022;8(3):420–444.
    1. Jiang Y., Mao F., Li Y., et al. Construction of China cardiovascular health index. BMC Public Health. 2018;18(1):937.
    1. World health statistics 2022: monitoring health for the SDGs, sustainable development goals [Internet] Available from:
    1. China health statistical yearbook 2020 [Internet] Available from:
    1. Bulletin on the State of China’s ecological environment 2019 [Internet] Available from:
    1. Xin L., Gao Y., Cheng Z., et al. Utilization and quality assessment of digestive endoscopy in China: results from 5-year consecutive nationwide surveys. Chin Med J. 2022;135(16):2003–2010.
    1. Zhou X.Z., Lyu N.H., Zhu H.Y., et al. Large-scale, national, family-based epidemiological study on Helicobacter pylori infection in China: the time to change practice for related disease prevention. Gut. 2023;72(5):855–869.
    1. Gao Y., Xin L., Lin H., et al. Machine learning-based automated sponge cytology for screening of oesophageal squamous cell carcinoma and adenocarcinoma of the oesophagogastric junction: a nationwide, multicohort, prospective study. Lancet Gastroenterol Hepatol. 2023;8(5):432–445.
    1. Xin L., Gao Y., Wang T.J., et al. EUS development in China: results from national surveys in 2013 and 2020. Endosc Ultrasound. 2023;12(1):90–95.
    1. Hasson F., Keeney S., McKenna H. Research guidelines for the Delphi survey technique: Delphi survey technique. J Adv Nurs. 2000;32(4):1008–1015.
    1. Schmidt K., Aumann I., Hollander I., Damm K., von der Schulenburg J.M.G. Applying the analytic hierarchy process in healthcare research: a systematic literature review and evaluation of reporting. BMC Med Inform Decis Mak. 2015;15(1):112.
    1. Zhou M., Liu J., Jiang Y., et al. Use of the cardiovascular health index to assess cardiovascular health in China: an integral innovative approach. Lancet. 2018;392
    1. Mabe K., Inoue K., Kamada T., Kato K., Kato M., Haruma K. Endoscopic screening for gastric cancer in Japan: current status and future perspectives. Dig Endosc. 2022;34(3):412–419.
    1. Kanth P., Inadomi J.M. Screening and prevention of colorectal cancer. BMJ. 2021;374
    1. Ward J.E., Young J.M., Jilfs P. Population-based cancer control: where is the greatest benefit from proven strategies to ‘Regain’ years of life lost prematurely? Aust N Z J Public Health. 1999;23(5):538–540.
    1. Săftoiu A., Hassan C., Areia M., et al. Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europe: European Society of Gastrointestinal Endoscopy (ESGE) position statement. Endoscopy. 2020;52(4):293–304.
    1. Zong L., Abe M., Seto Y., Ji J. The challenge of screening for early gastric cancer in China. Lancet. 2016;388(10060):2606.
    1. National Cancer Center, China. Expert Group of the Development of China Guideline for the Screening. Early Detection and Early Treatment of Colorectal Cancer China guideline for the screening, early detection and early treatment of colorectal cancer (2020, Beijing) Zhonghua Zhong Liu Za Zhi. 2021;43(1):16–38.
    1. He J., Chen W.Q., Li Z.S., et al. China guideline for the screening, early detection and early treatment of esophageal cancer (2022, Beijing) Zhonghua Zhong Liu Za Zhi. 2022;44(6):491–522.
    1. Status of cardiovascular disease epidemics and its risk factors prevention and control in China: an evaluation based on China cardiovascular health index of 2017. Zhonghua Yu Fang Yi Xue Za Zhi. 2021;55(11):1280–1286.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere